Previous research published in JAMA Network Open showed a nearly 65% discontinuation rate for three GLP-1s (liraglutide, semaglutide, or tirzepatide) among adults with overweight or obesity and without type 2 diabetes
The Victims of GLP-1 Drugs Across Industries Figure 2, Average Weight Loss Across Treatments (%) Diabesity-Related Surgical & Medical Devices Sleep Apnea Obstructive sleep apnea (OSA) is a common problem among obese patients (around 40% of obese patients suffer from OSA), while around 70% of OSA patients are obese [15]
Seek immediate medical attention if you experience large volumes of bright red blood, dizziness or fainting, severe abdominal pain, vomiting blood, black tarry stools, or signs of significant blood loss such as rapid heart rate or confusion
When they looked at genetic data from more than 4,500 adults, they found that people with certain variants in this gene have lower blood sugar levels while taking GLP-1 drugs
Targets Ther